|Articles|May 1, 2002
New brimonidine formulation has improved tolerability profile
Brimonidine tartrate 0.2% (Alphagan, Allergan) has been shown to confer neuroprotection in a number of ocular injury models when applied topically or systemically.1
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
























